This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lu, W. Articles by Dong, Z. Search for Related Content PubMed PubMed Citation Articles by Lu, W. Articles by Dong, Z.

Active Specific Immunotherapy against Occult Brain Metastasis¹

Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

We determined whether lyophilized High Five (H5) insect cells engineered to produce IFN-ß (H5BVIFN-ß) could induce systemic immunity against occult brain metastases. C3H/HeN mice were injected s.c. with syngeneic UV-2237M fibrosarcoma or K-1735M2 melanoma cells. Intralesional injection of 2 x 10⁶ lyophilized H5BVIFN-ß cells produced complete regression of the s.c. tumors. Six weeks later, UV-2237M fibrosarcoma cells or K-1735M2 melanoma cells were injected into the internal carotid artery of naive or treated mice. UV-2237M brain metastases developed in naive mice or mice cured of K-1735M2 tumors but not in mice cured of UV-2237M tumors. Similarly, K-1735M2 brain metastases developed in naive mice or mice cured of UV-2237M fibrosarcomas but not in mice cured of K-1735M2 melanoma. In the next set of studies, mice were injected s.c. with UV-2237M fibrosarcoma cells. On day 7, UV-2237M fibrosarcoma cells or K-1735M2 cells were implanted into the internal carotid artery, and on day 10, the s.c. tumors were injected with lyophilized H5BVIFN-ß. Both the s.c. tumors and the occult brain metastases produced from carotid injections were eradicated in a tumor-specific manner. The regression of the brain metastases was abrogated by depletion of CD4⁺ or CD8⁺ cells from immunized mice. These results demonstrate that specific systemic immunity can be induced by lyophilized H5BVIFN-ß and that the resultant immune response can eliminate established brain metastasis.